Related Experiment Video
Updated: Jan 8, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Mechanisms of glutamate metabolic function and dysfunction in vascular dementia
Jiawen Wang1, Yingmei Zhang1,2, Ning Tian1
1Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University Guilin Medical University Guilin Guangxi China.
Insights
Vascular dementia (VaD) involves brain blood supply issues. This study explores how regulating glutamate metabolism may offer new prevention and treatment strategies for VaD.
Area of Science:
- Neuroscience
- Neurology
- Gerontology
Background:
- Dementia research is crucial as global populations age.
- Vascular dementia (VaD) is the second most common dementia type, stemming from impaired brain blood supply.
- VaD presents complex neurological and behavioral challenges.
Purpose of the Study:
- To investigate the link between vascular dementia and glutamate metabolism.
- To explore glutamate metabolism regulation as a potential therapeutic target for VaD.
- To identify improved methods for VaD prevention and treatment.
Main Methods:
- Review of existing literature on VaD pathogenesis.
- Analysis of the role of glutamate in brain function and dysfunction.
- Exploration of the connection between cerebral hypoperfusion and glutamate excitotoxicity.
Main Results:
- Reduced brain blood flow in VaD contributes to excessive glutamate accumulation.
- Glutamate excitotoxicity is a key mechanism leading to neuronal death in VaD.
- Abnormal glutamate metabolism is strongly associated with dementia development.
Conclusions:
- Regulating glutamate metabolism presents a promising avenue for VaD treatment.
- Targeting glutamate pathways could lead to novel strategies for preventing and managing VaD.
- Further research into glutamate's role is essential for advancing VaD therapies.
Abstract:
As the global population ages, research on the pathogenesis and treatment options for older patients with dementia has become increasingly important. Vascular dementia (VaD), the second most frequent type of dementia, is characterized by vascular impairment caused by inadequate blood supply to the brain. VaD is a complex neurological disorder involving multiple cells and signaling pathways, and its prevention and treatment pose clinical challenges with significant behavioral implications. Glutamate, the most abundant amino acid in the brain, plays a critical role as an excitatory neurotransmitter, impacting cognitive function, learning, and memory. Abnormal glutamate metabolism has been closely linked to dementia, and reduced blood flow to the brain can lead to excessive glutamate accumulation, resulting in neuronal death. This article highlights the connection between VaD and glutamate metabolism, aiming to identify better methods for preventing and treating VaD via regulating glutamate metabolism.
Related Concept Videos
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Antiepileptic Drugs: Glutamate Antagonists
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

